Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia

Pathology and Oncology Research

Volumn 11, Issue 1, 2005, Pages 26-31

  Sobel, Gábor ^a   Szabó, István ^a   Páska, Csilla ^a   Kiss, András ^a   Kovalszky, Ilona ^a   Kádár, Anna ^a   Paulin, Ferenc ^a   Schaff, Zsuzsa ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Carcinogenesis; Cervical intraepithelial neoplasia; Claudin; Occludin; Syndecan 1

Indexed keywords

CLAUDIN; CLAUDIN 1; CLAUDIN 2; CLAUDIN 4; CLAUDIN 7; OCCLUDIN; SYNDECAN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; TIGHT JUNCTION; UTERINE CERVIX CARCINOMA IN SITU;

EID: 18444401972     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032402     Document Type: Article

References (41)

1. Acharya P, Beckel J, Ruiz WG, et al: Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium. Am J Physiol Renal Physiol 287: F305-F318, 2004
2. Anttonen A, Kajanti M, Heikkila P, et al: Syndecan-1 expression has a prognostic significance in head and neck carcinoma. Br J Cancer 79: 558-564, 1999
3. Anttonen A, Heikkila P, Kajanti M, et al: High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer 32: 297-305, 2001
4. Bazer-Garner IB, Dilaz B, Sanderson RD and Smoller BR: Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma. Am J Dermatopathol 22: 119-122, 2000
5. Billings SD, Walsh SV, Fisher C, et al: Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultra-structural correlation. Mod Pathol 17: 141-149, 2004
6. Chiba H, Gotoh T, Kojima T, et al: Hepatocyte nuclear factor (HNF)-4a triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells. Exp Cell Res 286: 288-297, 2003
7. Fujiya M, Watari J, Ashida T, et al: Reduced expression of syndecan1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res 92: 1078-1081, 2001
8. Furuse M, Fujita K, Hiiragi T, et al: Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141: 1539-1550, 1998
9. Giroglou T, Florin L, Schäfer F, et al: Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75: 1565-1570, 2001
10. Gumbiner BM: Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357, 1996
11. Hirohashi S, Kanai Y: Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581, 2003
12. Hodivala KJ, Watt FM: Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol 124: 589-600, 1994
13. Hughes DE, Rebello G, Al-Nafussi A: Integrin expression in squamous neoplasia of the cervix. J Pathol 173: 97-104, 1994
14. Inki P, Stenback F, Grenman S, Jalkanen M: Immunohistochemical localization of syndecan in normal and pathological human uterine cervix. J Pathol 172: 349-355, 1994
15. Johnson LG: Applications of imaging techniques to studies of epithelial tight junctions. Adv Drug Deliver Rev 57: 111-121, 2005
16. Kominsky SL, Argani P, Korz D, et al: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22: 2021-2033, 2003
17. Langbein L, Grund C, Kuhn C, et al: Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Europ J Cell Biol 81: 419-435, 2002
18. Litvinov SV, van Driel W, van Rhijn CM, et al: Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol 148: 865-875, 1996
19. Mikami S, Ohashi K, Usui Y, et al: Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 92: 1062-1073, 2001
20. Miwa N, Furuse M, Tsukita S, et al: Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 12: 469-476, 2000
21. Morita K, Tsukita S, Miyachi Y: Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br J Dermatol 151: 328-334, 2004
22. Nakanishi K, Yoshioka N, Oka K, Hakura A: Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3' untranslated region. Int J Cancer 80: 527-532, 1999
23. Nichols LS, Ashfaq R and Iacobuzio-Donahue CA: Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol 121: 226-230, 2004
24. Numa F, Hirabayashi K, Kawasaki K, et al: Syndecan-1 expression in cancer of the uterine cervix: association with lymph node metastasis. Int J Oncol 20: 39-43, 2002
25. Páska C, Bögi K, Szilák L, et al: Effect of formalin, acetone and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn Mol Path 13: 234-240, 2004
26. Peppi M, Ghabriel MN: Tissue specific expression of the tight junction proteins claudins and occludin in the rat salivary glands. J Anat 205: 257-266, 2004
27. Rangel LB, Agarwal R, D'Souza T, et al: Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9: 2567-2575, 2003
28. Rintala J, Inki P, Klemi P, et al: Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. Gynecol Oncol 75: 372-378, 1999
29. Schneeberger EE, Lynch RD: The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286: C1213-C1228, 2004
30. Shafti-Keramat S, Handisurya A, Kriehuber E, et al: Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol 77: 13125-13135, 2003
31. Sobel G, Szabó I, Kiss A, et al: Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol 36: 162-169, 2005
32. Tímár J, Lapis K. Dudáx J, et al: Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol 12: 173-186, 2002
33. Tobioka H, Isomura H, Kokai Y, et al: Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 35: 159-164, 2004
34. Tobioka H, Tokunaga Y, Isomura H, et al: Expression of occludin, a tight-junction-associated protein, in human lung carcinomas. Virchows Arch 445: 472-476, 2004
35. Tokés A-M, Kulka J, Paku S, et al: Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7: R296-R305, 2005
36. Tsukita S, Furuse M, Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293, 2001
37. Turksen K, Troy T-C: Barriers built on claudins. J Cell Sci 117: 2435-2447, 2004
38. Wiksten JP, Lundin J, Nordling S, et al: Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer 95: 1-6, 2001
39. Woodworth CD, Waggoner S, Barnes W, et al: Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res 50: 3709-3715, 1990
40. Yang Y, Yaccoby S, Liu W, et al: Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood 100: 610-617, 2002
41. Zheng JY, Yu D, Foroohar M, et al: Regulation of the expression of the prostate-specific antigen by claudin-7. J Membr Biol 194: 187-197, 2003